Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
Efficacy of cancer immunotherapies relies on correct recognition of tumor antigens by lymphocytes, eliciting thus functional responses capable of eliminating tumor cells. Therefore, important efforts have been carried out in antigen identification, with the aim of understanding mechanisms of respons...
Saved in:
| Main Authors: | Belen Aparicio, Patrick Theunissen, Sandra Hervas-Stubbs, Puri Fortes, Pablo Sarobe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2303799 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances and challenges in neoantigen prediction for cancer immunotherapy
by: Yi Zhang, et al.
Published: (2025-06-01) -
Targeting Antigen‐Presenting Cells to Enhance the Tumor‐Spleen Immunity Cycle through Liposome‐Neoantigen Vaccine
by: Yu Xu, et al.
Published: (2025-05-01) -
Neoantigens: new hope for cancer therapy
by: Yitong Hu, et al.
Published: (2025-03-01) -
Shared neoantigens for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-06-01) -
Multi-omics and AI-driven immune subtyping to optimize neoantigen-based vaccines for colorectal cancer
by: Karthick Vasudevan, et al.
Published: (2025-06-01)